The treatment of urinary candidosis with the oral antifungal drugs 5-fluorocytosine and 'clotrimazole'.
D000015:Abnormalities, Multiple; D000935:Antifungal Agents / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D001230:Aspergillus / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D003455:Cryptococcus neoformans / Q000187:drug effects; D003596:Cytosine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D005437:Flucytosine / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D005658:Fungi / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D003904:Mitosporic Fungi / Q000187:drug effects; D009089:Mucor / Q000187:drug effects; D013175:Sporothrix / Q000187:drug effects; D014249:Trichophyton / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000935:Antifungal Agents; D007093:Imidazoles; D003596:Cytosine; D005437:Flucytosine